Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test
06. Dezember 2022 07:03 ET
|
Lucira Health Inc.
Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and...
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
17. November 2022 07:03 ET
|
Lucira Health Inc.
Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira...
PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 6th
27. November 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 27, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Corporation Publishes White Paper and Data on its Successful Detection of Zika Virus
16. November 2016 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 16, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID’s Chief Technology Advisor Chairs Healthcare Innovation Panel at National Defense Industrial Association Health Affairs Biodefense Summit
25. Oktober 2016 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Oct. 25, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype
13. Januar 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Jan. 13, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
PositiveID Corporation Signs Agreement With U.S. Special Operations Command
06. November 2014 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 6, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
PositiveID Corporation Publishes Its Featured Presentation From Biodetection Technologies 2013 Conference
18. Juni 2013 16:05 ET
|
PositiveID Corporation
Chief Technology Advisor Dr. Kimothy Smith's presentation available on PositiveID's website
DELRAY BEACH, Fla., June 18, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company")...
PositiveID Corporation Reviews 2012 Highlights and 2013 Outlook
12. März 2013 08:50 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., March 12, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today issued...
PositiveID Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3
06. Februar 2013 16:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Feb. 6, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced...